You have 6 free searches left this month | for more free features.

Vaccine re-challenge

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dengue Trial in Baltimore (Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose, Dengue 4 Live Virus Human Challenge

Recruiting
  • Dengue
  • Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
Mar 1, 2022

Malaria Trial in Seattle (PfSPZ Vaccine, PfSPZ Challenge (7G8) for CHMI, Normal Saline)

Completed
  • Malaria
  • PfSPZ Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 15, 2022

Immunising Mums Against Pertussis 3

Completed
  • Whooping Cough
  • +2 more
  • Pre-school booster vaccine
  • Gloucester, United Kingdom
  • +2 more
Apr 8, 2022

Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)

Recruiting
  • Shigella
  • SF2a-TT15 Shigella Vaccine
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022

Malaria Trial in London, Southampton (RH5.1/ ASO1)

Completed
  • Malaria
  • RH5.1/ ASO1
  • London, United Kingdom
  • +1 more
Dec 6, 2021

Respiratory Syncytial Virus Infections Trial in London (RSVPreF, Placebo)

Completed
  • Respiratory Syncytial Virus Infections
  • RSVPreF
  • Placebo
  • London, United Kingdom
    Golam Kabir
Sep 1, 2021

BCG Vaccination on Infectious and Immune Mediated Diseases

Enrolling by invitation
  • BCG Vaccination Reaction
  • +3 more
  • BCG
  • Placebo vaccine
  • Nijmegen, Gelderland, Netherlands
    Radboud university medical center
Oct 25, 2022

Shigella Trial in Baltimore (CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a)

Terminated
  • Shigella
  • CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
  • Baltimore, Maryland
  • +1 more
Apr 27, 2021

Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)

Recruiting
  • Vaccine Response Impaired
  • BCG vaccine
  • +3 more
  • Adelaide, South Australia, Australia
    South Australian Health and Medical Research Institute
Nov 17, 2023

Immune Response Trial in Oxford (Keyhole-Limpet Hemocyanin, Saline, Montanide ISA 51 VG)

Recruiting
  • Immune Response
  • Keyhole-Limpet Hemocyanin
  • +3 more
  • Oxford, United Kingdom
    NIHR Oxford Experimental Medicine Clinical Research Facility
May 16, 2023

Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi (S. Typhi))

Unknown status
  • Salmonella Typhi Infection
  • Salmonella Typhi (S. Typhi)
  • Oxford, Oxfordshire, United Kingdom
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropic
Dec 9, 2021

Malaria Trial in Bamako (biological, drug, other)

Completed
  • Malaria
  • PfSPZ Vaccine
  • +5 more
  • Bamako, Mali
    University of Bamako (USTTB/MRTC)
Apr 19, 2021

COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)

Recruiting
  • COVID-19
  • Corona Virus Infection
  • Pfizer-BioNTech mRNA COVID-19 vaccine
  • Moderna mRNA COVID-19 vaccine
  • Ann Arbor, Michigan
    University of Michigan
Apr 23, 2022

Shigellosis Trial in Baltimore (Flexyn2a, Placebo)

Completed
  • Shigellosis
  • Flexyn2a
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health, CIR
Jan 7, 2021

Enterotoxigenic Escherichia Coli Infection, Diarrhea Trial in Baltimore (VLA1701, Placebo, Challenge Strain)

Completed
  • Enterotoxigenic Escherichia Coli Infection
  • Diarrhea
  • VLA1701
  • +2 more
  • Baltimore, Maryland
    Department of International Health Johns Hopkins University
Mar 29, 2021

Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)

Not yet recruiting
  • Infectious Disease
  • +3 more
  • Stamaril
  • +2 more
  • (no location specified)
Oct 3, 2022

Cholera Trial in Baltimore, Cincinnati, Burlington (PXVX0200, )

Completed
  • Cholera
  • PXVX0200
  • placebo
  • Baltimore, Maryland
  • +2 more
Mar 5, 2021

Volunteer Screening for Vaccine and Antivirals Clinical Trials

Completed
  • Normal Physiology
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 30, 2021

    Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)

    Not yet recruiting
    • Shigellosis
    • Bacillary Dysentery
    • 2.5 μg InvaplexAR-Detox
    • +3 more
    • Leiden, Netherlands
      Leiden University Medical Center
    Jul 26, 2023

    Influenza Trial in United States (Influenza A/Bethesda/MM2/H1N1 Challenge)

    Completed
    • Influenza
    • Influenza A/Bethesda/MM2/H1N1 Challenge
    • Baltimore, Maryland
    • +3 more
    Apr 1, 2021

    Malaria,Falciparum, Plasmodium Falciparum, Plasmodium Berghei Trial in Nijmegen, Rotterdam (Pb(PfCS@UIS4)-infected mosquitoes,

    Completed
    • Malaria,Falciparum
    • +3 more
    • Pb(PfCS@UIS4)-infected mosquitoes
    • Challenge infection P. falciparum
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Feb 23, 2022

    Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)

    Terminated
    • Shigella
    • CVD 1208S, a Shigella flexneri 2a live, oral vaccine
    • Placebo
    • Baltimore, Maryland
      University of Maryland, Baltimore Center for Vaccine Development
    Apr 27, 2021

    MALARIA, FEVER, Sweating Fever Trial in Cali (413ABM, 414WRR, 418JAL)

    Completed
    • MALARIA
    • +4 more
    • 413ABM
    • +2 more
    • Cali, Valle, Colombia
      Malaria Vaccine and Drug Development Center
    Feb 25, 2021

    Human Immunodeficiency Virus, Herpes Simplex Type II, Chlamydia Trial in Umlazi (Mentoring Adolescent Mothers at School (MAMAS))

    Completed
    • Human Immunodeficiency Virus
    • +4 more
    • Mentoring Adolescent Mothers at School (MAMAS)
    • Umlazi, South Africa
      Philasende Clinic
    Sep 20, 2021

    Melanoma Trial in Australia, New Zealand, United Kingdom (NY-ESO-1 ISCOMATRIX®, ISCOMATRIX® adjuvant)

    Completed
    • Melanoma
    • NY-ESO-1 ISCOMATRIX®
    • ISCOMATRIX® adjuvant
    • Camperdown, New South Wales, Australia
    • +14 more
    Oct 3, 2022